On this occasion, ZENOAQ has been selected as "Best Company in Asia/Australasia 2014"by Animal Pharm.
Animal Pharm is an enterprise based in Britain which analyzes and delivers worldwide information on animal health, medicines and functional materials. An international panel made up of 10 independent individual judges was chosen for the selection of the winning company.
ZENOAQ was selected as "Best Company" based on the development of the next generation hyposensitization therapeutic medicine Allermmune HDM for canine atopic dermatitis, a type of therapy that is expected to satisfy a significant unmet need in canines with house dust mite-induced atopic dermatitis. This is the first in a line of products for immunological ailments in companion animals under development at ZENOAQ.
The original announcement from Animal Pharm can be read by accessing the link below.
Being recognized with this Award is the result of the support and cooperation of our valued customers and business partners, to whom we are deeply grateful.
ZENOAQ will continue to strive with our technological skills and knowhow to create new original high-value products and services, for the well-being of animals and all our customers world-wide.
The AIJ March 2013 edition has been published. This month's article is "Animal Assisted Therapy or What??"････(read more)
The AIJ February 2013 edition has been published. This month's article is "Recent Pet Statistics for Japan"････(read more)
The AIJ January 2013 edition has been published. This month's article is "Tokyo Shelter for Disaster Victims Closes"････(read more)
Zenoaq is pleased to announce a new agreement naming Handok Biotech Co., Ltd as our exclusive distributor for the CELLBANKER range of innovative cell freezing media in Korea. Handok Biotech was established in 1991, and is a leading supplier of high quality products and innovative tools for biochemistry, molecular and cell biology research. Handok Biotech is an established distributor of various product brands including BD Biosciences, Eppendorf, Biontex, Innovative Research, and various ELISA kits, in Korea. This partnership is expected to provide our valued customers in Korea with increased access to the unique CELLBANKER range of products.
ZENOAQ work on Core Competence Management and Management Quality Improvement Program to achieve our corporate philosophy, and we put efforts to create our originality or distinctive competency of research, product, and expansion power.
ZENOAQ have taken control consistently of developing, manufacturing, importing, and selling veterinary pharmaceutical products. There are 41 branch offices in Japan to direct selling system. Manufacturing Plant and Research and Development Facility are compliant with GMP and GLP standards. We are only-one-company possessing Central Research Laboratory and Experimental Farm in Japan.
Also, we have been developing strong relationship with both Japanese and foreign good-standing companies in a positive manner.
Customers are able to choose from many selections as we have more than 400 kinds of product lineup, including in-house product and products from our business partner, for companion animal, production animal and reagent in laboratory use.
ZENOAQ is aiming to not only become a good-standing company in the business field but also a good corporate citizen as an individual. We always feel gratitude to everyone concerned and practice CSR through our activities as a member of society with placing great value on compliance.
Animals In Japan is the only website that you are able to get up-to-date information on animal circumstances in Japan in English. ZENOAQ is providing a subject from all topics on animals every month, to whom currently happens, such as animal welfare, environmental issues, food problem, display animal, test animal, service animal, child education, activities of animal-affiliated, and Japanese sense of value etc.